Hebei Yuxing Bio-Engineering Co. Ltd
Chinese pharmaceutical company
Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America.[1] Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination."[2]
References
- v
- t
- e
Pharmaceutical companies of China- CanSino Biologics
- CSPC Zhongrun
- China Nepstar
- Fosun Pharmaceutical
- Guangzhou Pharmaceuticals
- Guangyuyuan
- Guizhentang Pharmaceutical Company
- Harbin Pharmaceutical Group
- Hebei Yuxing Bio-Engineering Co. Ltd
- Huadong Medicine
- Jilin Aodong Medicine
- Lijun International Pharmaceutical (Holding) Co. Ltd.
- Kunming Pharmaceutical Corporation
- Nanjing Ange Pharmaceutical
- North China Pharmaceutical Group
- Salubris Pharmaceuticals
- Shanghai Pharmaceuticals Holding Co., Ltd.
- Shenzhen Kangtai Biological Products
- Shijiazhuang Pharma Group
- Sihuan Pharmaceutical
- Simcere Pharmaceutical
- China National Pharmaceutical Group
- Sinovac Biotech
- Tasly
- Tong Ren Tang
- Xiangxue Pharmaceutical
- Yangtze River Pharmaceutical Group
- Yunnan Baiyao Group
- WuXi AppTec
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
